InsiderClue
Stocks · Health care · Pharmaceutical Preparations

EXICURE, INC.

XCUR Clue Score25
United States Fiscal year ends December CIK 0001698530 Results filed 25 Mar 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

34
Insider
Date
Role
Action
Shares
Price
Amount
Exicure HiTron Inc.
21 Jan 2026
10% owner
Sell
258,367
$4.50
$1.16M
Exicure HiTron Inc.
16 Jan 2026
10% owner
Sell
734,747
$4.50
$3.31M
Exicure HiTron Inc.
7 Jan 2026
10% owner
Sell
741,272
$4.50
$3.34M
Sangsangin Investment & Securities Co., Ltd.
8 Dec 2025
10% owner
Sell
433,332
$8.71
$3.77M
Exicure HiTron Inc.
26 Dec 2024
10% owner
Buy
2,900,000
$3.00
left out
DGP Co., Ltd.
12 Sep 2024
10% owner
Buy
237,223
$3.00
$711.67K
DGP Co., Ltd.
29 Feb 2024
10% owner
Sell
3,400,000
$1.32
$4.49M
CBI USA, Inc.
15 Dec 2022
10% owner
Buy
3,400,000
$1.60
$5.44M
Bali Muralidhar
19 May 2022
Director
Buy indirect
1,472,126
$0.19
$285.15K
Gates Frontier, LLC
21 Dec 2021
10% owner
Sell
1,268,619
$0.24
$303.20K
Elias D. Papadimas
27 Aug 2021
Chief Accounting Officer
Buy indirect
10,000
$1.38
$13.80K
Jay Venkatesan
6 Jul 2020
Director
Exercised, kept
12,930
$1.03
$13.32K
Jay Venkatesan
6 Jul 2020
Director
Exercised, kept
9,310
$0.65
$6.05K
Chad A. Mirkin
12 Jun 2020
Director
Sell indirect
10,195
$2.83
$28.85K
Aurasense LLC
12 Jun 2020
10% owner
Sell
10,195
$2.83
$28.85K
Chad A. Mirkin
20 May 2020
Director
Exercised, kept
49,649
$0.65
$32.27K
David R Walt
13 Mar 2020
Director
Buy
291,066
$1.21
$352.86K
Chad A. Mirkin
12 Mar 2020
Director
Buy
15,000
$1.45
$21.75K
David S Snyder
12 Mar 2020
Chief Financial Officer
Buy
18,248
$1.40
$25.59K
Bali Muralidhar
19 Dec 2019
Director
Buy indirect
727,000
$2.75
$2.00M
David R Walt
2 Aug 2019
Director
Buy
1,000,000
$2.00
$2.00M
Jay Venkatesan
2 Aug 2019
Director
Buy
250,000
$2.00
$500.00K
Chad A. Mirkin
2 Aug 2019
Director
Buy indirect
25,000
$2.00
$50.00K
Chad A. Mirkin
22 Mar 2019
Director
Buy
500
$2.30
$1.15K
Chad A. Mirkin
21 Mar 2019
Director
Buy
1,000
$2.43
$2.43K
David A Giljohann
19 Mar 2019
Chief Executive Officer
Buy
7,000
$2.40
$16.80K
Chad A. Mirkin
18 Mar 2019
Director
Buy
1,000
$2.40
$2.40K
Chad A. Mirkin
13 Mar 2019
Director
Buy
2,200
$2.50
$5.50K
Mark N. Tompkins
26 Sep 2017
Former Director and 10% Owner
Buy
166,667
$3.00
$500.00K
Jay Venkatesan
26 Sep 2017
Director
Buy indirect
66,666
$3.00
$200.00K
David A Giljohann
26 Sep 2017
Chief Executive Officer
Buy
16,666
$3.00
$50.00K
David R Walt
26 Sep 2017
Director
Buy
268,333
$3.00
$805.00K
Ian Seth Jacobs
15 Jun 2017
President, Secretary, CEO, CFO
Sell
35,000
$0.03
$875.00
Mark N. Tompkins
15 Jun 2017
Director
Buy
35,000
$0.03
$875.00

What was left out

Form 4 filings counted 109
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 1
Shares from compensation/vesting 28,401,067
Sales filed before the plan box existed 4
History held since 19 Jun 2017